Latest News about TSHA
Recent news which mentions TSHA
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 08, 2022
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
February 22, 2022
From Benzinga
Two Insider Moonshots Rising on Sudden Buying
February 10, 2022
From InvestorPlace
Executives Buy Around $62M Of 3 Stocks
February 07, 2022
From Benzinga
Taysha Reports Efficacy, Safety Data From High Dose Cohort For Neurological Disorder Gene Therapy Trial
January 31, 2022
Tickers
TSHA
From Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
January 20, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 19, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
January 06, 2022
From Benzinga
Stocks Hitting New 52-Week Lows Today
January 03, 2022
From Benzinga
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
December 26, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2021
December 16, 2021
From Benzinga
The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré
December 07, 2021
From Benzinga
Taysha Gene Therapies, Inc. (TSHA) Q3 2021 Earnings Call Transcript
November 11, 2021
Tickers
TSHA
From Motley Fool
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
August 17, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 17, 2021
From Benzinga
From Benzinga
Tickers
TSHA
From Motley Fool
Earnings Scheduled For August 16, 2021
August 16, 2021
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 27, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.